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Summary 
Major histocompatibility complex (MHC) products and self-antigens expressed in the thymus 
determine the repertoire of mature or//3 T cells. While positive selection of self-MHC-restricted 
T  cells is directed by MHC molecules expressed by thymic epithelial cells, negative selection 
depends  to a large extent on self-antigens presented  by lymphohemopoietic cells. However, 
radioresistant components of the thymus also influence  negative sdection, but it remains controversial 
whether this is accomplished by clonal deletion, clonal anergy, or other mechanisms.  In this 
study,  T  cell development  in mice expressing a transgenic  T  cell receptor  (TCR) specific for 
lymphocytic choriomeningitis virus  (LCMV)  plus  H-2D  b was  analyzed  in  the presence  or 
absence of the viral antigen. A novel approach to analyze the thymic tissue requirements for 
negative selection was possible by comparing thymocyte selection in H-2D  b versus H-2D  bin13 
mice, since the latter allowed positive selection but not LCMV-specific deletion of transgenic 
TCR-expressing thymocytes. In irradiation bone marrow chimeras expressing the restriction element 
for negative selection (H-2D  b) on host tissue, we show that radioresistant recipient cells in the 
thymus deleted developing T cells at an early stage of differentiation. In contrast, chimeras expressing 
H-2D  b on  lymphohemopoietic donor cells showed clonal  deletion at  a  later  stage  during 
ontogeny. 
T 
he thymus provides a highly efficient environment for 
differentiation of T lymphocytes (1, 2). Engagement of 
the ot/~ TCR in immature T cells plays a critical role both 
in inducing the development  of T  cells beating receptors 
specific for foreign antigen presented by self-MHC molecules 
(positive selection), and the deletion of potentially harmful 
self-reactive T  cells (negative  selection).  The sequence of 
thymocyte developmental stages and the cellular interactions 
may provide important clues to understand how T cells "learn" 
to discriminate self from nonself. The cells involved in thymic 
selection have been analyzed extensively. It has become clear 
that positive selection is largely controlled by thymic epithe- 
lial cells (3-13). 
Negative selection, however, is influenced by both bone 
marrow-derived cells and thymic epithelia (5-7, 14-27).  It 
has been demonstrated that antigens presented by lympho- 
hemopoietic cells induce tolerance (reviewed in references 5, 
6, 14, and 15). For example, clonal deletion ofT cells specific 
for I-E + (28-30),  Mls-1  ~ (31, 32), Mls-2a/3 a (33), or staphy- 
loccocal enterotoxin B (SEB) (34) is induced by bone marrow- 
derived thymic cells (7, 21-23). In contrast, the role of thymic 
epithelial cells in negative selection is less defined. While early 
investigations  using thymus grafting failed to demonstrate 
negative sdection by the MHC molecules displayed  on thymic 
epithelium (35-37),  other studies in chimeras and/or trans- 
genic mice indicate that tolerance may be induced by thymic 
epithelial cells (16-22, 24-27).  Often it was not possible to 
determine whether nonresponsiveness was due to deletion, 
anergy, or other mechanisms. Recently,  it has been postu- 
lated that a nondeletional mechanism such as clonal anergy 
may occur when lymphocytes encounter their specific self- 
antigen on thymic epithelia (21, 22, 24, 25). However, while 
some authors claimed that thymic epithelial  cells induced 
anergy of Mls-la-specific T cells (21, 22), our comparative 
analysis indicated that Mls-la-spedfic anergy was induced by 
lymphohemopoietic cells (23). 
In this study transgenic mice were used carrying the P14 
TCR ot/~ chains (Vot2-Jc~TA31, V~8.1-DJ/~/2.4) specific for 
the lymphocytic choriomeningitis virus (LCMV) 1 glycopro- 
1 Abbreviations  used  in  this paper:  aa,  amino acids; LCMV, lymphocytic 
choriomeningitis  virus;  tg,  transgenic. 
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of H-2D  b (38).  Positive  selection  of transgenic T  cells has 
been shown to depend on the presence  of the H-2  b mole- 
cule, while clonal deletion occurred in H-2  b LCMV carrier 
mice (38). The virus carrier state (established by virus infec- 
tion either neonatally or during immunosuppression) was as- 
sociated with ubiquitous virus expression,  including thymic 
epithelia and lymphohemopoietic cells (39, 40). In this study 
the  respective  roles  of the  host's thymus versus  lympho- 
hemopoietic donor cells in clonal deletion was evaluated by 
investigating thymocyte maturation in LCMV carrier bone 
marrow chimeras.  The results show that transgenic T  cells 
were clonally deleted at different stages of development de- 
pending upon expression of the viral antigen restriction ele- 
ment H-2D  b either on host-derived radioresistant  or donor- 
derived lymphohemopoietic cells. 
Materials  and Methods 
Animals.  Inbred BALB/c (H-2  a) and C57BL/6J (H-2  b) mice 
were purchased from the Institute fiir Zuchthygiene (Tierspital, 
University of Zfirich, Switzerland). Breeders of the two C57BL/6 
H-2D  b mutant inbred mouse strains B6.C-H-2  bma3 and B6.C-H- 
2  bin14 (41, 42) (referred to as H-2  bin13 and H-2  bin14 mice) were kindly 
provided by Dr. Cornelis J. Melief (The Netherlands Cancer Insti- 
tute,  Amsterdam,  Holland).  H-2  bin13  mice express a  mutated 
H-2D b molecule with three amino acid changes at the bottom of 
the peptide antigen binding groove (B-pleated sheet) at positions 
114 (Leu ~  Gln), 116 (Phe-~Tyr), and 119 (Glu~Asp). The mu- 
tated H-2D bm~4 molecule has a single amino acid changed on the 
c~1 helix of the TCR binding site at position 70 (Gln~His) (42). 
The transgenic mouse line 327 expressing the c~/B TCR de- 
rived from  the  cytotoxic T  cell clone P14  specific H-2D b plus 
LCMV glycoprotein peptide aa 32-42 was generated by coinjec- 
tion of the P14 TcR c~ and B chain gene constructs into (C57BL/6 
x  DBA/2)Fz-fertilized eggs (38). The male founder 327 bearing 
10-20 copies of both cr and ~ transgenes integrated at the same 
chromosome was backcrossed to C57BL/6 mice. c~/B TCR trans- 
genic (tg) H-2  a and H-2  bma3 mice were obtained by backcrossing 
to BALB/c and B6.C-H-2  bm13, respectively.  Characteristics of the 
strains relevant to the present study are summarized in Table 1. 
Chimeras.  Bone  marrow recipients were lethally  irradiated (950 
tad,  117 rad/min, ~37Cs source) and reconstituted 1 d later with 
1-2  x  107 T cell-depleted bone marrow cells as described (3). To 
establish a I.CMV carrier state, chimeras  were infected  intravenously 
with 5 x  1@ PFU of LCMV-WE strain 4-14 h after bone marrow 
transfer. For the following 5 wk, chloramphenicol  (0.4 g/liter) was 
added to the drinking water. Both infected  and noninfected  chimeras 
had a survival rate of 85-100%. Analysis  was performed between 
8 and 12 wk after reconstitution.  Chimerism was monitored by 
FACS  |  analysis (Becton Dickinson & Co., Mountain View, CA) 
of lymph node cells with H-2 haplotype-specific mAbs. 
Virus, MLR, and Cytotoxicity  Assay.  The WE strain of LCMV 
had been originally  obtained from Dr. Fritz Lehmann-Grube  (Ham- 
burg, FRG) (43). Virus stocks were diluted in MEM supplemented 
with 2% FCS. To examine the functional response of T cells from 
activities of chimeric mice, spleen cells (4  x  10S/ml)  were cultured 
with irradiated (2,000 rad) LCMV-infected  peritoneal macrophages 
(4  x  104/ml) from C57BL/6 mice in 96-well plates. Cell prolifer- 
ation was determined after 3 d by 10-h [3H]thymidine  uptake. The 
lytic activity of spleen cells from chimeras infected 4 d earlier with 
5  x  1@ PFU LCMV-WE intravenously was determined against 
LCMV-infected and uninfected MC57G (H-2  b) target cells in 5-h 
SlCr-release assays as described previously (3). 
CytofluorographicAnalysis.  Aliquots  of  untreated thymocytes  or 
lymph node cells were stained at 4~  in balanced salt solution (BSS) 
containing 2% FCS and 0.2% NaN3 with rat mAbs B20.1 (Vc~2 
specific; reference 44) or KJ16-133 (VB8.1/VB8.2 specific; refer- 
ence 31) detected with FITC goat anti-rat lgG (Tago Inc., Burlin- 
game, CA). Biotinylated CD8-specific mAb 53-6.7 (Becton Dick- 
inson & Co.) detected with avidin-PE (Tago Inc.) or PE-conjugated 
CD4-specific mAb GK 1.5 (Becton  Dickinson & Co.), respectively, 
was used for double staining.  To assess the chimerism  of transplanted 
mice, haplotype-specific  mAbs H141-31 (D  b specific), K7-309 (K  b 
specific), or 34-2-12 (D  d specific), respectively,  were used followed 
by fluorescent goat anti-mouse IgG or IgG2a reagents (Southern 
Biotechnology Associates, Inc., Birmingham, AL); samples were 
similarly  double stained as described  above. Viable  cells (20,000 per 
sample) were analyzed by flow cytometry on an Epics profile ana- 
lyzer (Coulter Electronics, Inc., Hialeah, FL) with logarithmic  scales. 
Results 
Early Deletion by Host Radioresistant Cells of  Maturing Thymo- 
cytes in LCMV Carrier Bone Marrow Chimeras.  (C57BL/6 
x  BALB/c)F1  mice  were  lethally  irradiated  and  recon- 
stituted with T cell-depleted P14 ol/~ TCR transgenic bone 
marrow from either H-2  b or H-2  d mice. To establish a virus 
carrier state,  chimeras were infected with 5  x  106 PFU of 
LCMV strain WE (LCMV-WE) between 4 and 14 h after 
irradiation and bone marrow reconstitution. Livers and spleens 
obtained up to 30 wk after infection contained ~106 PFU 
LCMV per gram organ (data not shown), confirming that 
these mice were virus carriers.  Between 8 and 12 wk after 
bone marrow transplantation, T cell maturation was analyzed 
by flow cytometry with mAbs specific  for the transgenic TCR 
domains Vc~2 (B20.1) and V~8.1 (KJ16).  A  strong reduc- 
tion of thymocytes expressing the transgenic TCR was ob- 
served in F1 chimeric virus carriers reconstituted with either 
H-2  b or H-2  a transgenic bone marrow (Fig.  1 c and d). The 
extent of deletion was comparable with nonchimeric virus 
carriers published previously (38) and similar to the deletion 
described in other class I-restricted cr  TCR transgenic 
mouse models (8, 9). In contrast, thymocytes  from uninfected 
control chimeras expressed transgenic Vol2 (Fig.  1, a and b) 
and V~/8.1 (not shown) at high levels. Lymph node cells in 
uninfected chimeras were "~40% Vc~2+CD8 +, whereas in 
chimeric virus carriers <2% were Vol2 +  CD8 + (not shown). 
In summary, the data suggest that radioresistant thymic cells 
expressing  the appropriate restriction element H-2D  b in H- 
2d---~H-2  bxd carrier  mice induced clonal deletion of virus- 
specific CTL precursors. 
Deletion by LymphohemoFoietic Cells Occurred  at a Later Stage 
of T  Cell Differentiation.  Since bone marrow chimeras in- 
evitably contain remaining radioresistant lymphohemopoietic 
cells of host origin, further experiments were necessary to 
evaluate the possible involvement of the thymic epithelium 
for induction of clonal deletion. A  conventional protocol 
would have been to generate fully aUogeneic or F1 "+ parent 
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Figure 1.  LCMWH-2Db-specific  ot/B TCR transgenic thymocytes  de- 
veloping in the absence (uninfected;  a and b) or presence (LCMV carriers; 
c and d) of the viral antigen. Unseparated thymocytes were stained with 
mAb B20.1 specific  for the transgenic V~2 chain. Both H-2  b (c) and H-2d 
(d) bone marrow-reconstituted (C57BL/6  x  BALB/c)F1  chimeras car- 
rying the l.CM-virus deleted transgenic V~2 + cells at an early stage of 
differentiation. Comparable  histograms were obtained from stainings with 
KJ16 specific for the transgenic 3 chain (data not shown). Broken lines 
indicate control thymocytes  stained  with fluorescein-conjugated  goat anti-rat 
antibodies alone. Comparable results were obtained from at least four in- 
dividual chimeras per group. We have  been unable to explain the reprodu- 
cibly higher amount of TCR  hi cells in group b as compared with a. 
bone marrow chimeras or the engraftment of thymectomized 
mice with parental thymus implants.  However, positive se- 
lection of the transgenic ot/3 TCR depended on the expres- 
sion of H-2D  b by the thymic epithelium,  thus excluding the 
possibility  to  study  negative  selection  in  H-2Db-negative 
thymi. This experimental problem could be circumvented as 
follows. 
H-2  brat3 mice  express  a  mutated  H-2D b molecule  with 
three amino acid changes at the bottom of the peptide an- 
tigen binding  groove (42).  The P14  transgenic oe/3 TCR 
can be positively selected in the context of H-2D bmt3 prod- 
ucts (P.  S. Ohasi and H,  P. Pitcher, manuscript in prepara- 
tion).  However, H-2D  b~13 molecules are unable to present 
the viral epitope (LCMV glycoprotein aa 32-42) to the trans- 
genic TCR.  Furthermore, transgenic H-2  bin13 LCMV carrier 
mice are unable to clonally delete the transgenic TCR (Table 
1)  (unpublished  results).  Finally,  H-2  bma4 mice,  another 
H-2D  b mutant  mouse strain,  neither promote positive nor 
negative selection of the P14 transgenic c~/3 TCR, and were 
therefore ideally used as closely related controls. 
The  unique  property  of H-2D  bin13 molecules  allowing 
positive but not negative selection of the transgenic TCR 
offered a  new  methodological  approach  to  overcome  the 
known  problem  of  radioresistant  or  2'-deoxyguanosine- 
resistant residual lymphohemopoietic cells "contaminating" 
the thymus of irradiation bone marrow chimeras or thymus- 
transplanted mice. To study the capacity of the thymic epi- 
thelium for clonal deletion, irradiation chimeras were gener- 
ated by injection of transgenic T  cell-depleted bone marrow 
into either H-2  b ￿  bin13 or H-2  bm13 ￿  bm14 F1 hosts. When ana- 
lyzed 8-12 wk later, uninfected control chimeras revealed high 
levels of transgenic Vol2 + and V38.1 + thymocytes (Table 2 
and  Fig.  2,  a,  c,  and  e).  Chimeric  virus  carriers  donally 
ddeted  transgenic  T  cells  resulting  in  low  levels  of both 
TCR int/hi thymocytes as well as of mature  cells in  the pe- 
riphery (Table 2 and Fig. 2, b and f). Interestingly, in H-2  b 
H.2bmt3  ￿  bml4 virus carriers, a subpopulation of thymo- 
cytes expressing the transgenic TCR at low (TCR  l~  den- 
sity was found (Fig. 2 d) that was absent in H-2b-expressing 
hosts (Figs.  1 d and 2f). In H-2  b --~ H-2  bin13 x bml4 carriers, 
clonal deletion was induced by lymphohemopoietic tissue, 
since the restriction dement H-2D b capable of viral antigen 
presentation causing deletion was not expressed by host radio- 
resistant tissue. Thus, deletion induced by lymphohemopoietic 
cells occurred at a later stage ofT call differentiation and was 
therefore distinguishable from deletion induced by host radio- 
resistant cells. Thymocytes from the various chimeras showed 
similar forward light  scatters  (not shown),  indicating that 
they were of similar size. This permitted direct comparison 
of the TCR  expression levels measured. 
To assess  the tolerance status  of transgenic T  cells from 
Table  1.  Characteristics  of (~/3  TCR  Transgenic (tg) Mice Used in  This Study 
H-2 compatible  H-2  Negative selection 
nontransgenic  Positive selection  of the tg TCR 
tg mice  mouse strain  K  I  D  of the tg TCR  in LCMV carriers 
tg  H-2  b  C57BL/6  b  b  b  +  + 
tg H-2  bin13  B6.C-H2  b~13  b  b  bm13  +  - 
tg  H-2  bm14  B6.C-H2  bin14  b  b  bin14  -  - 
tg H-2  d  BALB/c  d  d  d  -  - 
In uninfected mice, the P14 tg ot/3 TCR is positively selected  in the context of both H-2D  b and H-2D  bml3 resulting in high TCR expression (~95% 
of T cells express the transgenes) and skewing to the CD8 lineage. In congenitally or neonatally infected LCMV carrier mice expressing the viral 
antigen in the thymus (39, 40), negative selection of the transgenic TCK is due to thymic clonal deletion occurring in association with H-2D b but 
not H-2D bin13 or H-2D  b~14 (38, and P. S. Ohashi and H. P. Pitcher, manuscript in preparation). 
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tg H-2  b'~  tg  H-2  b''~  tg  H-2  bmt3-'~ 
H.2  b x bml3  H.2bm13 x bin14  H_2  b x bm13 
LCMV  LCMV  LCMV 
Tissue  Uninfected  carrier  Uninfected  carrier  Uninfected  Carrier 
Percent cells positive for: 
Vc~2 to~,  Thymus  43.0  _+  8.1  6.0  _+  0.3  49.5  +_  2.4  33.3  +-  6.2  41.1  +_  6.9  9.4  +  1.1 
VB8.1  ~~  Thymus  30.1  _+  3.1  10.9  +_  3.2  47.6  _+  2.8  33.7  _  8.9  43.3  _+  7.9  11.8  _+  2.9 
Vot2  i~'/h~  Thymus  43.4  _+  6.9  2.7  _+  1.1  35.4  _+  5.6  3.3  -+ 0.6  41.3  _+  12.3  3.2  _+  1.4 
V/~8.1  int/hi  Thymus  38.7  +_ 3.9  2.1  +_ 0.6  32.1  +_  1.9  2.9  +- 0.3  40.3  _+  11.2  1.9  +_ 0.7 
Va2*CD8 +  Lymph node  49.3  _+  4.3  1.2  _+  0.2  61.0  _+  3.1  1.7  -+  0.2  42.0  _+  4.9  0.8  _+  0.1 
V38.1+CD8 §  Lymph node  56.2  _+  1.2  1.6  +_  1.3  58.3  _+  3.3  2.2  -+  0.4  44.6  _+  5.3  1.2  _+  2.5 
Proliferative  responses  (cpm) 
to LCMV infected  Spleen  37.0  x  103  0.9  x 103  72.7  x  103  0.2  x  103  42.8  x  103  1.0  x  103 
C57BL/6  stimulators 
Percent  specific cytolysis of targets 
(E/T ratio  70:23:8:3) 
MC57G LCMV infected  Spleen 
MC57G uninfected  Spleen 
YAC-1  Spleen 
70:60:51:23  7:5:0:0  78:57:38:21  1:0:7:9  62:47:23:14  8:5:6:4 
5:3:3:3  2:1:5:3  7:2:0:0  9:5:6:5  3:5:6:2  3:8:0:3 
4:3:0:0  1:0:1:3  8:5:1:3  3:2:7:7  7:1:0:0  1:1:5:1 
Mean  _+ SEM are from FACS  |  analyses of unseparated cell preparations of three to five chimeras per group. Examples of FACS  |  profiles from one 
chimera per group are shown in Fig. 2. The percentages for low or int/hi positive cells, respectively, refer to the regions given in Fig. 2. Percent 
Vot2 +  CD8 + or percent V~8.1 +  CD8 § indicate the percentages of lymph node cells expressing both the transgenic TCR variable regions and CD8. 
Proliferative responses were measured by [3H]thymidine  uptake (10 h) after stimulation with LCMV-infected peritoneal macrophages (3 d). Cytotox- 
icity was analyzed 4 d after intravenous infection with 106 PFU LCMV-WE. Chimerism assessed with mAb K7-309 (K  b specific, positively staining 
all lymph node cells) and mAb H141-31 (D  b specific, staining H-2D  b+ cells strongly but H-2D  brat3+ lymphocytes only at low fluorescence intensi- 
ties; reference 47) showed that  ~90%  of lymph node cells were of donor type. 
the various chimeras,  proliferation  and cytotoxic T  cell re- 
sponses  were  tested  (Table  2).  While  noncarrier  chimeras 
responded vigorously to LCMV-infected stimulator or target 
cells,  both LCMV-specific proliferative responses  and cyto- 
toxic T  cell activities were low in the chimeric carrier mice 
(Table 2). Thus, all the noncarrier chimeras were T cell com- 
petent against LCMV and all the carriers were nonrespon- 
sive correlating with  presence or absence of mature  trans- 
genic T  cells  in  thymus and periphery. 
Discussion 
In the past,  the  technical difficulty to completely elimi- 
nate  lymphohemopoietic  cells  from  thymic  tissue  while 
preserving its capacity to promote T cell maturation has been 
a limiting factor to experimentally determine whether thymic 
epithelial cells can induce clonal deletion. Therefore, we studied 
negative selection  in H-2D  b mutant mice. Since H-2  ~13  ￿  ~4 
mice selected the transgenic TCtL positively but not nega- 
tively (P.  S.  Ohasi,  manuscript  submitted for publication), 
it was not essential that lymphohemopoietic cells were com- 
pletely eliminated by irradiation  to assess  the contribution 
of donor lymphohemopoietic cells to negative selection.  In 
chimeric H-2  b ~  H-2  brat3  ~ bin14 virus carriers,  clonal dele- 
tion induced by lymphohemopoietic cells was at the TCR  l~ 
stage of thymocyte ontogeny.  In contrast,  only transgenic 
TCR-negative  lymphocytes remained  in  virus  carriers  ex- 
pressing  H-2D  b on radiation-resistant  thymic cells.  There- 
fore, these cells probably including thymic epithelial cells are 
apparently capable to induce clonal deletion at an early stage 
of ontogeny. 
An alternative explanation based on the assumption that 
deletion can only be induced by lymphohemopoietic cells can 
be  postulated.  The  presence  of TCR  l~  cells  in  H-2  b 
H_2bm13  ￿  b~14 carrier  chimeras  could  possibly  be  due  to 
"delayed" deletion caused by insufficient repopulation of the 
thymic microenvironment by donor cells.  However, this as- 
sumption would imply that deletion in H-2  d -,- H-2  b ￿  d or 
H_2bm13 ..~  H_2  b ~ bm13 carriers  was  due  to  low  amounts 
of remaining  lymphohemopoietic  cells.  Accordingly,  one 
would  also  expect  a  complete  and  early  deletion  in 
H_2  b __,  H_2bm13 ￿  b~14 carrier  chimeras,  where  donor cells 
had repopulated  the  thymus  (45).  Thus,  since we did  not 
find early deletion in H-2  b ~  H-2  bin13 ￿  bin14 carriers where 
deletion was induced by lymphohemopoietic cells, we con- 
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Figure 2.  l.CMWH-2Db-specific ot//~ TCR transgenic thymocytes developing in the absence (uninfected;  a, c, and e) or presence (LCMV carriers; 
b, d, and f) of the viral antigen. The histograms represent examples from data given in Table 2. Unseparated thymocytes were double stained with 
transgenic Vc~2 or Vj88.1 chain-specific mAbs and a CDS-specific mAb. The histograms shown were software gated for the CD8 + cells (including 
CD8 + and CD4 +  8 +). In chimeric LCMV carriers, expression of H-2D  b by radioresistant host tissue induced early deletion (b and f) while H-2  bin13 ￿  bm14 
recipients deleted thymocytes at a TCR  l~  stage (d). The regions marked low or int/hi indicate low or intermediate/high TCR densities, respectively, 
and refer to the text and data given in Table 2. Additional results (not shown) were obtained from transgenic H-2  b ~  H-2  b or H-2  b -,- H-2  bm13 chimeras, 
respectively, revealing comparable results to Fig. 2, a and b or c and d, respectively. 
dude that the early deletion in H-2  a "-* H-2  b ￿  d or H-2  bm13 
_.,H.2 b ￿  bin13 carriers was induced by radioresistant thymic 
host cells,  presumably the thymic epithelium. 
The results imply that the thymic epithelium may be in- 
volved in both positive and negative selection. Subpopula- 
tion of the different epithelial cells within the thymic cortex 
and medulla may exhibit distinct self antigens and functions 
(24-27,  37,  46).  Alternatively, different affinity thresholds 
may regulate positive or negative selection (5). One may argue 
that our transgenic T cells were deleted early due to presum- 
ably high avidity interactions with radioresistant thymic cells. 
It is also possible that the observed differences in deletion 
may be because thymocytes first encounter epithelial cells and 
only later interact with lymphohemopoietic cells. 
Our findings support the notion that T ceils may be sus- 
ceptible to donal deletion over an extended period of thymic 
differentiation. Furthermore, several of the various thymic 
cell components may induce negative selection. Thus,  the 
immune system may have developed a variety of ways to in- 
crease the probability of self-specific  lymphocytes encountering 
self-antigens in order to assure efficient induction and main- 
tenance of immunological tolerance. 
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